CJ Barnum

VP of Neuroscience, INmuneBio

[Buffalo Bills @BuffaloBills]

DOUBLE VOTES DAY!!!

REPOST to #ProBowlVote for @JoshAllenQB and for your chance to win a helmet signed by him.

https://t.co/CBL4QIAONd | #BillsMafia

[Dion Dawkins @DDawkins66]

If we get this retweet to more then 5k retweets I’ll send a lucky fan a pro bowl Jersey #ProBowlVote #DionDawkins

[INmune Bio Inc. @INmuneBio]

Our CFO David Moss penned an article in @HCBizToday on how the current landscape of #AlzheimersDisease treatment cost poses the question of what advantage is gained from spending a fortune on current #Alzheimers therapies that only delay the inevitable?: https://t.co/YLCoA1quxL

[INmune Bio Inc. @INmuneBio]

Our therapeutic product INKmune™ is a novel NK-priming platform against resistant tumors that have shown to kill cells of ovarian #cancer, breast cancer, prostate cancer, and many others. Learn more from our Chief Scientific Officer, Mark Lowdell, PhD: https://t.co/8xAt7RDglA

[INmune Bio Inc. @INmuneBio]

Our CEO Dr. RJ Tesi recently provided insight in a @BioCentury report by Executive Editor @SelinaMKoch highlighting #Alzheimers clinical trials post-#aducanumab approval and the future implications of this historic decision. Access the full article here: https://t.co/1PrSjnipBo

[UF McKnight Brain Institute @UFMBI]

Congratulations to @UF neuroimmunologist Dr. @MaluTansey, for earning the 2020 J. William Langston Award from @MichaelJFoxOrg for her dedication to advancing Parkinson's disease research and improving the lives of patients. @UFCTRND @UFHealth https://t.co/GKFgEqY4In

[CJ Barnum @cjbarnu]

Congratulations @MaluTansey and @elandhuis on an excellent article on targeting #inflammation in #Alzheimers. #xpro1595

https://t.co/jUVTXYBVXy

[CJ Barnum @cjbarnu]

#COVID19 #clinicaltrials https://t.co/oX6VpaiqOW

[CJ Barnum @cjbarnu]

https://t.co/CZItJlvi99

[CJ Barnum @cjbarnu]

@INmuneBio is honored to have support from @NIH to examine the potential of #XPro1595 in treatment-resistant depressed patients with #inflammation biomarkers. https://t.co/Oaly2yvJ5o

[CJ Barnum @cjbarnu]

2/2 What distinguishes #INB03 from the currently available first-generation TNF inhibitors? Selectivity.

The result is a potent anti-inflammatory drug that does not suppress the #immune systems ability to fight infection.

https://t.co/dt0eXZ2EYR

[CJ Barnum @cjbarnu]

1/2 The evidence for targeting #TNF in COVID19 patients keeps accumulating.

@INmuneBio will be testing our next generation selective TNF inhibitor #INB03 in #COVID19

https://t.co/n3yZVvT2g5

[The Science of Parkinson's @ScienceofPD]

WOW! An overview & analysis of 2019-2020 clinical drug development pipeline for #Parkinsons - both symptomatic & disease modifying.

Amazing analysis of the clinical trial landscape from PD research (super) advocates @InnovationFixer Sue Buff & @grafaloff
https://t.co/uK85PxtMW9

[Prof. Melissa E. Murray 📸🔬 @DrNeuroChic]

Fantastic presentation by @MaluTansey emphasizing microglia are not innocent bystanders in Alzheimer's disease #AAIC20 #AAIC2020

[CJ Barnum @cjbarnu]

On the eve of #AAIC20 I would like to issue a personal invitation to join me in donating what you can to the @alzassociation to help end #alzheimers disease! https://t.co/Gg2ifmBwTo

[CJ Barnum @cjbarnu]

Treating 'atomic bomb' caused by coronavirus https://t.co/vSfcyg8qvB

[CJ Barnum @cjbarnu]

Excellent interview with INmune Bio Inc. CEO RJ Tesi discussing the data we released this morning from our Phase 1 #alzheimers trial. #inflammation #clinicaltrials
https://t.co/nu0BABSoQ1

[INmune Bio Inc. @INmuneBio]

Have you registered yet for our #webinar happening tomorrow at 8 AM EST? We will be reviewing the XPro1595 Phase Ib Interim Data of #Neuroinflammation in Patients with #AlzheimersDisease. Register now: https://t.co/ig1muEb6TA

[CJ Barnum @cjbarnu]

@INmuneBio to Announce Interim Data from Phase Ib Clinical Study of XPro1595 in Patients with #Alzheimers Disease. #inflammation #clinicaltrials https://t.co/9EH9FxJZHD

[CJ Barnum @cjbarnu]

Excited to participate in the #Neuroimmunology Drug Development Summit! Check it out here: https://t.co/Pqeai4QUSR